Could Imiquimod (5% Aldara) or Other TLR7 Agonists be Used in The Treatment of COVID-19?

Toll-like receptor 7 is critical in recognition of single strand RNA viruses, including SARS CoV-2, and generation of anti-viral immunity Coronaviruses evolved strategies to dampen the host immunity Herein, we discuss the potential use of TLR7 agonists in early stages of COVID-19